Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A KEITH

Showing results (821-830 of 918) with videos related to

Pageof 92
Sort By:
Mayo Clinic Proceedings|April 23, 2021
Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice SettingJennifer L Anderson, Teresa M Kruisselbrink, Emily C Lisi, et al.
Annals of Hematology|April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patientsVerónica González-Calle, Abigail Slack, Niamh Keane, et al.
The Lancet. Oncology|December 3, 2014
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 studyShaji K Kumar, Jesus G Berdeja, Ruben Niesvizky, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective StudyPedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Blood|February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Leukemia Research|October 17, 2013
The clinical significance of cereblon expression in multiple myelomaSteven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 9, 2010
Establishing IUCN Red List criteria for threatened ecosystemsJon Paul Rodríguez, Kathryn M Rodríguez-Clark, Jonathan E M Baillie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
Multidisciplinary model to implement pharmacogenomics at the point of carePedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, et al.
Plos One|February 8, 2014
Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangementsJan B Egan, Michael T Barrett, Mia D Champion, et al.
Blood|May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemiaXinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
Pageof 92

Showing results (821-830 of 918) with videos related to

Sort By:
Pageof 92
Mayo Clinic Proceedings|April 23, 2021
Clinically Actionable Findings Derived From Predictive Genomic Testing Offered in a Medical Practice SettingJennifer L Anderson, Teresa M Kruisselbrink, Emily C Lisi, et al.
Annals of Hematology|April 7, 2018
Evaluation of Revised International Staging System (R-ISS) for transplant-eligible multiple myeloma patientsVerónica González-Calle, Abigail Slack, Niamh Keane, et al.
The Lancet. Oncology|December 3, 2014
Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 studyShaji K Kumar, Jesus G Berdeja, Ruben Niesvizky, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 16, 2021
Germline Cancer Susceptibility Gene Testing in Unselected Patients with Hepatobiliary Cancers: A Multi-Center Prospective StudyPedro Ls Uson Junior, Katie L Kunze, Michael A Golafshar, et al.
Blood|February 5, 2011
Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2Nikhil C Munshi, Kenneth C Anderson, P Leif Bergsagel, et al.
Leukemia Research|October 17, 2013
The clinical significance of cereblon expression in multiple myelomaSteven R Schuster, K Martin Kortuem, Yuan Xiao Zhu, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|November 9, 2010
Establishing IUCN Red List criteria for threatened ecosystemsJon Paul Rodríguez, Kathryn M Rodríguez-Clark, Jonathan E M Baillie, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|September 23, 2016
Multidisciplinary model to implement pharmacogenomics at the point of carePedro J Caraballo, Lucy S Hodge, Suzette J Bielinski, et al.
Plos One|February 8, 2014
Whole genome analyses of a well-differentiated liposarcoma reveals novel SYT1 and DDR2 rearrangementsJan B Egan, Michael T Barrett, Mia D Champion, et al.
Blood|May 27, 2008
Cyproheptadine displays preclinical activity in myeloma and leukemiaXinliang Mao, Sheng-ben Liang, Rose Hurren, et al.
Pageof 92